Clinical TrialID 3556
Policosanol for the Treatment of Hypercholesterolemia
NCT00255216
Hyperlipidemia
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 3556
- Evidence Id
- 3556
- Core Evidence Id
- 3556
- Source Clinical Trial Id
- 3530
- Herb2 Clinical Trial Id
- HBCT003530
- Nct Id
- NCT00255216
- Title
- Policosanol for the Treatment of Hypercholesterolemia
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Hyperlipidemia
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Policosanol supplement (oral capsule) vs. placebo
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 40
- Outcome Measure
- Primary Outcome Variables:|Percent change in LDL-C between baseline and 8 weeks in the policosanol and placebo arms.
- Sponsor Collaborator
- Wake Forest University Health Sciences
- Funded By
- OTHER
- Location
- Center for Cardiovascular Health, Charlotte, North Carolina, 28207, United States
- Other Id
- Poli-01
- Start Date
- 2005-01
- Primary Completion Date
- Completion Date
- 2005-08
- First Posted
- 2005-11-18
- Results First Posted
- Last Update Posted
- 2023-03-30
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00255216
- Title Cn
- Title En
- Policosanol for the Treatment of Hypercholesterolemia
- Bilingual Status
- semi_complete